Suchergebnisse - "Laferrière, Craig"

PubPharm (36)

1

enthalten in: Europäisches Patentamt | 2021

von CAPIAU CARINE | DESCHAMPS MARGUERITE | DESMONS PIERRE MICHEL | +3

2

Target Product Profile Analysis of COVID-19 Vaccines in Phase III Clinical Trials and Beyond : An Early 2021 Perspective

enthalten in: Viruses | 2021

von Funk, C. | Laferrière, C. | Ardakani, A.

3

A Snapshot of the Global Race for Vaccines Targeting SARS-CoV-2 and the COVID-19 Pandemic

enthalten in: Frontiers in pharmacology | 2020

von Funk, C. | Laferrière, C. | Ardakani, A.

4

Vaccine strategies for prevention of community-acquired pneumonia in Canada : Who would benefit most from pneumococcal immunization?

enthalten in: Canadian family physician Medecin de famille canadien | 2019

von Kaplan, A. | Arsenault, P. | Aw, B. | +16

5

Effectiveness of 13-Valent Pneumococcal Conjugate Vaccine Against Invasive Disease Caused by Serotype 3 in Children : A Systematic Review and Meta-analysis of Observational Studies

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2019

von Sings, H. | De Wals, P. | Gessner, B. | +7

ErratumIn: Clin Infect Dis. 2021 May 4;72(9):1684-1685. - PMID 33576382

6

Cost-effectiveness of alternative strategies for use of 13-valent pneumococcal conjugate vaccine (PCV13) in Canadian adults

enthalten in: Canadian journal of public health = Revue canadienne de sante publique | 2018

von Atwood, M. | Beausoleil, L. | Breton, M. | +3

7

Cost-effectiveness of alternative strategies for use of 13-valent pneumococcal conjugate vaccine (PCV13) in Canadian adults

enthalten in: Canadian journal of public health | 2018

von Atwood, M. | Beausoleil, L. | Breton, M. | +3

8

Cost-effectiveness of alternative strategies for use of 13-valent pneumococcal conjugate vaccine (PCV13) in Canadian adults

enthalten in: Canadian journal of public health | 2018

von Atwood, M. | Beausoleil, L. | Breton, M. | +3

9

Cost-effectiveness of alternative strategies for use of 13-valent pneumococcal conjugate vaccine (PCV13) in Canadian adults

enthalten in: Canadian journal of public health | 2018

von Atwood, M. | Beausoleil, L. | Breton, M. | +3

10

Vacuna contra Streptococcus pneumoniae

enthalten in: Europäisches Patentamt | 2018

von LAFERRIERE CRAIG ANTONY JOSEPH | POOLMAN JAN